PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 54 filers reported holding PDS BIOTECHNOLOGY CORP in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $347,531 | +2.7% | 68,818 | +2.3% | 0.00% | – |
| Q2 2023 | $338,373 | -47.0% | 67,271 | -35.2% | 0.00% | – |
| Q1 2023 | $638,738 | -78.4% | 103,860 | -53.6% | 0.00% | – |
| Q4 2022 | $2,953,303 | +6320.2% | 223,735 | +1350.9% | 0.00% | – |
| Q3 2022 | $46,000 | -11.5% | 15,420 | +7.3% | 0.00% | – |
| Q2 2022 | $52,000 | -49.5% | 14,371 | -13.6% | 0.00% | – |
| Q1 2022 | $103,000 | -38.0% | 16,625 | -18.7% | 0.00% | – |
| Q4 2021 | $166,000 | +95.3% | 20,450 | +257.1% | 0.00% | – |
| Q3 2021 | $85,000 | -89.7% | 5,726 | -91.3% | 0.00% | – |
| Q2 2021 | $825,000 | +6246.2% | 65,703 | +2254.9% | 0.00% | – |
| Q1 2021 | $13,000 | +225.0% | 2,790 | +64.1% | 0.00% | – |
| Q4 2020 | $4,000 | -71.4% | 1,700 | -72.1% | 0.00% | – |
| Q3 2020 | $14,000 | – | 6,100 | +22492.6% | 0.00% | – |
| Q4 2019 | $0 | – | 27 | -48.1% | 0.00% | – |
| Q3 2019 | $0 | – | 52 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 52 | -5.5% | 0.00% | – |
| Q1 2019 | $0 | – | 55 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INSPIRION WEALTH ADVISORS, LLC | 330,874 | $1,670,914 | 0.33% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $2,020,000 | 0.28% |
| AMUSSEN HUNSAKER ASSOCIATES LLC | 75,016 | $377,330 | 0.08% |
| Nebula Research & Development LLC | 25,708 | $129,825 | 0.07% |
| Corton Capital Inc. | 22,091 | $111,560 | 0.06% |
| Sofinnova Investments, Inc. | 142,635 | $720,307 | 0.04% |
| LAZARI CAPITAL MANAGEMENT, INC. | 11,000 | $55,550 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 24,369 | $123,063 | 0.02% |
| WINTON GROUP Ltd | 21,256 | $107,343 | 0.01% |
| Truvestments Capital LLC | 1,372 | $6,929 | 0.00% |